Skip to main content


Shire PLC (SHPGY): Today's Featured Drugs Loser

Shire was a leading decliner within the drugs industry, falling $1.16 (-1.3%) to $86.32 on light volume.

Shire PLC (SHPGY): Today's Featured Health Care Winner

Shire was a winner within the health care sector, rising $2.13 (2.2%) to $98.32 on light volume.

Shire's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Shire's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Shire Stock To Go Ex-dividend Tomorrow (SHPGY)

The ex-dividend date for Shire (Nasdaq:SHPGY) is tomorrow, March 7, 2012. Owners of shares as of market close today will be eligible for a dividend of 38 cents per share. At a price of $103.18 as of 9:30 a.m., the dividend yield is 0.4%.

Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval

Last week's positive panel sets up Chelsea nicely for an FDA approval in late March.

Breaking News

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.